COMPOSÉ HÉTÉROCYCLIQUE- Brevets EP1889842 (A1)

COMPOSÉ HÉTÉROCYCLIQUE

N° de brevet:	EP1889842 (A1)
Date de publication:	2008-02-20
Inventeur(s):	YAMAMOTO HIROSHI [JP];OHE YASUHIRO [JP];GOTO HIROYUKI [JP];HARADA KAZUHITO [JP];YATA SHINJI [JP];NISHIU JUN [JP];KAKUTANI MAKOTO [JP];FUJII SHUNSUKE [JP];ASAHINA KOTA [JP];ITO TAKASHI [JP];
Demandeur(s):	JAPAN TOBACCO INC [JP];
Classification:	C07D401/14;A61K31/454;A61K31/4545;A61K31/506;A61K45/00;A61P3/04;A61P3/06;A61P3/10;A61P9/12;A61P43/00;C07D409/14;C07D417/14;C07C205/53;C07D207/277;C07D207/26;C07D207/08;
N° de demande:	EP20060757326 20060608
Numéro(s) de priorité:	WO2006JP311975 20060608;JP20050168901 20050608;US20050692039P 20050617;JP20060027097 20060203;US20060772734P 20060213;JP20060138252 20060517

The present invention provides a compound represented by the following formula [1'] or a salt thereof: wherein ring A, R 2 , R 3 , R 4 and X are as defined in the description, and an agent for the treatment or prophylaxis of a pathology involving glucocorticoid, or a 11²HSD1 inhibitor, containing the compound or a salt thereof.